OBJECTIVE: The purpose of the study was to test the hypotheses that maternal treatment with dexamethasone leads to a reduction in basal umbilical blood flow and diminishes the fetal umbilical hemodynamic response to acute hypoxemic stress in sheep. STUDY DESIGN: While under general anesthesia, 23 ewes and their fetuses were instrumented with vascular catheters and transonic blood flow probes around a uterine and umbilical artery at 117 days of gestation (term, approximately 145 days). At 124 days, the ewes were injected intramuscularly with 2 doses of either dexamethasone (12 mg) or saline solution at 24-hour intervals. All animals experienced 2 episodes of hypoxemia during treatment (125+/-1 days) and after treatment (128+/-1 days). RESULTS: Maternal dexamethasone treatment caused a sustained increase in fetal arterial blood pressure (from 41+/-3 mm Hg to 45+/-3 mm Hg) and a transient fall in umbilical vascular conductance (from 6.2+/-0.9 mL. min(-1). [mm Hg](-1) to 5.4+/-0.7 mL. min(-1). [mm Hg](-1)). During both episodes of hypoxemia, there was a significant increase in umbilical blood flow in the controls, but not in the dexamethasone-treated animals. CONCLUSION: Maternal dexamethasone treatment with doses used in human clinical practice significantly decreased basal umbilical vascular conductance and prevented the normal increase in umbilical blood flow that is induced by acute hypoxemia in fetal sheep.
OBJECTIVE: The purpose of the study was to test the hypotheses that maternal treatment with dexamethasone leads to a reduction in basal umbilical blood flow and diminishes the fetal umbilical hemodynamic response to acute hypoxemic stress in sheep. STUDY DESIGN: While under general anesthesia, 23 ewes and their fetuses were instrumented with vascular catheters and transonic blood flow probes around a uterine and umbilical artery at 117 days of gestation (term, approximately 145 days). At 124 days, the ewes were injected intramuscularly with 2 doses of either dexamethasone (12 mg) or saline solution at 24-hour intervals. All animals experienced 2 episodes of hypoxemia during treatment (125+/-1 days) and after treatment (128+/-1 days). RESULTS: Maternal dexamethasone treatment caused a sustained increase in fetal arterial blood pressure (from 41+/-3 mm Hg to 45+/-3 mm Hg) and a transient fall in umbilical vascular conductance (from 6.2+/-0.9 mL. min(-1). [mm Hg](-1) to 5.4+/-0.7 mL. min(-1). [mm Hg](-1)). During both episodes of hypoxemia, there was a significant increase in umbilical blood flow in the controls, but not in the dexamethasone-treated animals. CONCLUSION: Maternal dexamethasone treatment with doses used in human clinical practice significantly decreased basal umbilical vascular conductance and prevented the normal increase in umbilical blood flow that is induced by acute hypoxemia in fetal sheep.
Authors: Christopher A Lear; Miriam E Koome; Joanne O Davidson; Paul P Drury; Josine S Quaedackers; Robert Galinsky; Alistair J Gunn; Laura Bennet Journal: J Physiol Date: 2014-11-10 Impact factor: 5.182
Authors: Wen Tong; Beth J Allison; Kirsty L Brain; Olga V Patey; Youguo Niu; Kimberley J Botting; Sage G Ford; Tessa A Garrud; Peter F B Wooding; Caroline J Shaw; Qiang Lyu; Lin Zhang; Jin Ma; Tereza Cindrova-Davies; Hong Wa Yung; Graham J Burton; Dino A Giussani Journal: Hypertension Date: 2022-05-09 Impact factor: 9.897
Authors: Alison J Forhead; Juanita K Jellyman; Miles J De Blasio; Emma Johnson; Dino A Giussani; Fiona Broughton Pipkin; Abigail L Fowden Journal: Endocrinology Date: 2015-06-03 Impact factor: 4.736
Authors: Noor E W D Teulings; Tessa A C Garrud; Youguo Niu; Katie L Skeffington; Christian Beck; Nozomi Itani; Fiona G Conlon; Kimberley J Botting; Lisa M Nicholas; Thomas J Ashmore; Heather L Blackmore; Wen Tong; Emily J Camm; Jan B Derks; Angela Logan; Michael P Murphy; Susan E Ozanne; Dino A Giussani Journal: FASEB J Date: 2020-06-05 Impact factor: 5.834